Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study) (AIR)

December 18, 2013 updated by: University of Zurich
Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Study Type

Interventional

Enrollment (Actual)

74766

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • ZH
      • Zurich, ZH, Switzerland, 8091
        • University Hospital Zurich, Center for Clinical Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • all in-patients in treatment with an intravenous antiinfective for >60h,
  • hospitalized in a ward with computerized physician order entry (cpoe)

Exclusion criteria:

  • outpatients,
  • ward without cpoe,
  • no intravenous antiinfective treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders
Other: electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders
Other Names:
  • computerized decision support
No Intervention: no electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents without computerized decision support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
duration of intravenous antiinfective therapy until switching
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
costs (per year, per day and patient)
Time Frame: 1 year
1 year
defined daily doses (per 100 days)
Time Frame: 1 year
1 year
duration of hospitalization
Time Frame: 1 year
1 year
ratio of narrow to broad-spectrum antibiotics
Time Frame: 1 year
1 year
requests for consultations
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Zurich

Investigators

  • Principal Investigator: Juerg Blaser, Professor, University Hospital Zurich, Center for Clinical Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

November 15, 2011

First Submitted That Met QC Criteria

December 22, 2011

First Posted (Estimate)

December 26, 2011

Study Record Updates

Last Update Posted (Estimate)

December 19, 2013

Last Update Submitted That Met QC Criteria

December 18, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FZMI-KEK-ZH-Nr. 2010-0457

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infection as Complication of Medical Care

Clinical Trials on electronic reminders

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe